In addition, ANKRD22 promoted cell proliferation and angiogenesis of NSCLC cells in vitro and in vivo, suggesting that ANKRD22 acts as an oncogene during the progression of NSCLC. Here, ANKRD22 is linked to non-small cell lung carcinoma.